(August 27 07:01) Dailymail.co.uk
A study of 27 at-risk 12 to 15-year-olds in the UK that were double-jabbed with Pfizer found only one experienced severe tiredness, discomfort and agitation, while the rest had mild symptoms.
You can find the original article
here